methyl (R)-1-(1-phenylet 98% White Powder JNE-006 ERIC

 Jining Eric Biomedical Technology Co., Ltd. is a biomedical high-tech enterprise, the company to the broad demand for anti-tumor drugs as the focus of entrepreneurship, with independent intellectual property rights of organic small molecule anti-tumor drugs as the main research and development products, engaged in anti-tumor drugs and related pharmaceutical intermediates research and development, production and sales. The company's team members have strong scientific research ability, management experience and theoretical foundation. The company makes full use of its strong scientific research strength and strives to promote the industrialization of high-tech and scientific research achievements in colleges and universities. Adhering to the cultural concept of "co-creation and sharing, common promotion and common reputation", the company takes customer satisfaction as its own responsibility and provides high-quality and efficient products and services; With the management concept of innovation, pragmatism, harmony and development, we pay attention to corporate culture and team building, and work together with upstream and downstream enterprises and employees to develop and make progress together. Deeply implement the scientific outlook on development, take reform and opening up as the driving force, improve independent innovation ability as the core, promote high-tech industrialization as the purpose, highlight the leading industrial expansion, optimize and upgrade products, expand and build the industrial chain, promote comprehensive supporting reform, coordinate resource integration, gather innovation elements, optimize functional configuration, develop emerging industries, build the company's brand, and build our company into a comprehensive industrial entity focusing on product development, production and sales of the international advanced level through efforts.